亚太地区解剖病理学市场预测至 2028 年 - 按产品和服务（仪器、消耗品和服务）、应用（疾病诊断、药物发现和开发等）和最终用户（医院、研究）划分的 COVID-19 影响和区域分析实验室、诊断实验室等）
市场介绍
解剖病理学是研究和治疗的重要组成部分疾病。解剖病理学是一个广泛的领域，包括尸体病理学、外科病理学、细胞病理学、神经病理学和眼科病理学。解剖病理学通常在医院的医学实验室和诊断实验室进行。
< span>市场概况和动态
预计到 2028 年，亚太地区解剖病理学市场将从 2019 年的 35.5633 亿美元增至 56.9776 亿美元。 2021 年；预计2021年至2028年复合年增长率为7.0%。市场的增长归因于几个关键驱动因素，例如抗癌药物临床试验数量的增加以及新技术开发和产品推出的不断增加在解剖病理学中。然而，缺乏熟练的专业人员和严格的政府法规的实施阻碍了市场的增长。
全球进行的癌症诊断程序数量为随着疾病患病率的增加而增加。尽管在癌症预防、诊断和治疗方面取得了重大进展，但对于肺癌、前列腺癌、乳腺癌等主要癌症类型的治疗仍有大量未满足的医疗需求。临床试验在医学进步和癌症发展中发挥着重要作用。循证医疗保健。这些试验有可能提高所有被诊断患有癌症的人的护理标准。许多研究人员正在进行临床试验，以测试针对常见和罕见癌症类型的新疗法。截至 2019 年 12 月，FDA 已总共批准了 47 种免疫疗法，几乎涵盖所有主要癌症类型。这些药物现在是许多癌症的标准治疗方法。临床试验找到了预防、诊断和治疗癌症的更好方法。由于药物经过临床试验后获得批准，许多癌症患者的寿命更长，生活质量得到改善。病理学在临床试验的每个阶段都发挥着重要作用。因此，抗癌药物临床试验数量的增加可能会支持未来几年解剖病理学市场的增长。基于机器学习 (ML) 和人工智能 (AI) 的系统在医学领域（包括解剖病理学）的集成空间巨大。一些解剖病理学实验室越来越意识到数字化和人工智能在实践中的好处。此外，最近的技术进步和监管部门的批准正在鼓励实验室运营的数字化，以提高流程的速度和准确性。正确设计的基于人工智能的工具在提高病理学工作流程效率和诊断准确性方面具有巨大潜力。人工智能技术在推进病理成像方面具有潜力，可以提高诊断精度，从而实现更具体的治疗。数字病理学是解剖病理学中一个不断发展的子领域，它使用数字技术来简化数据收集和管理。此外，数字病理学可以减少样本到结果的周转时间并简化中央病理学审查流程，进一步提供提高试验效率的机会。市场上的各种参与者都致力于为患者提供创新的解决方案。此外，成像服务提供商 RadNet 和诊断产品开发商 Hologic 合作开发乳腺健康人工智能工具。因此，在预测期内，新技术和新产品的引入很可能成为解剖病理学市场的一个重要趋势。
国家由于 COVID-19 病例不断增加，亚太地区正面临着巨大的挑战。考虑到经济运行和地理条件，疫情的爆发对医疗旅游、诊断试剂盒和药品的生产、供应链和分销产生了不利影响。由于该地区低收入国家医疗基础设施短缺，它还引发了其他问题。为防止新型冠状病毒传播，印度、韩国、新加坡、马来西亚和菲律宾等国家已采取限制措施。这些措施扰乱了所有行业，例如癌症诊断。根据国家卫生研究院最近发表的一篇文章，2020 年 4 月，印度德里医院收治的癌症患者面临着巨大的困难，因为医院忙于应对新冠病毒，他们的治疗、诊断和进展检查测试被推迟。 19 例。此外，在印度，疫情给本已脆弱的实验室带来了挑战，包括劳动力供应、交通、个人防护设备和小工具的缺乏、必需品采购的延迟、财务周转率的下降以及工作人员的担忧。一些实验室部门在封锁期间全天候工作，为常规病例和 COVID-19 病例提供诊断设施。此外，组织病理学和细胞学工作量大幅减少，阻碍了亚太地区解剖病理学市场的增长。
< strong>主要细分市场
根据产品和服务，亚太解剖病理学市场分为仪器、耗材和服务。服务细分市场在 2021 年占据最大市场份额，而仪器细分市场预计在预测期内的市场复合年增长率最高。
按应用划分，亚太解剖病理学市场分为疾病诊断、药物发现和开发等。疾病诊断细分市场在 2021 年占据最大的市场份额。然而，药物发现和开发细分市场预计在 2021 年至 2028 年期间将实现最高的市场复合年增长率。
亚太解剖病理学市场根据最终用户分为医院、研究实验室、诊断实验室等。其他部分包括制药和生物技术公司以及合同研究组织（CRO）。 2021 年，医院细分市场占据最大市场份额，预计诊断实验室细分市场在预测期内的复合年增长率最高。
主要来源和上市公司
一些主要和次要来源 在准备亚太解剖病理学市场报告时提到的印度肾脏病学会（ISN）、韩国糖尿病协会（KDA）、日本糖尿病教育和护理协会（JADEC）。和国家生物技术信息中心 (NCBI)。
购买报告的理由
- 根据详细的趋势分析确定潜在投资领域 未来几年的亚太解剖病理学市场。
- 深入了解底层推动支出最高的国家/地区对不同成瘾治疗药物细分市场需求的因素，并确定每个细分市场提供的机会。
- 加强您对市场需求驱动因素、行业趋势和最新技术发展等方面的了解。
- 确定主要渠道推动亚太解剖病理学市场，提供未来机会的清晰蓝图，有助于分析，从而实现收入扩张。
- 重点关注亚太解剖病理学市场内不同国家/地区正在进行的项目，引导资源 >.
亚太地区解剖病理学市场细分
按产品和服务
- 服务
- 消耗品
- < span>工具
按应用
- 疾病诊断
- 药物发现与开发
- < span>其他
最终用户
- 医院
- 研究实验室
- 诊断实验室
- < span>其他
按国家/地区
- 印度
- 日本
- 韩国
- 澳大利亚
- 中国
- 亚太其他地区
< span>公司简介
- F.霍夫曼拉罗氏有限公司
- 丹纳赫
- Hologic, Inc.
- 安捷伦科技公司
- BioGenex
- Diapath SpA
- Bio SB
- MERCK KGaA
- BD
- PHC控股公司
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Anatomic Pathology Market – By Product and Services
1.3.2 Asia Pacific Anatomic Pathology Market – By Application
1.3.3 Asia Pacific Anatomic Pathology Market – By End User
1.3.4 Asia Pacific Anatomic Pathology Market – By Country
2. Anatomic Pathology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Anatomic Pathology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinions
5. Anatomic Pathology Market — Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Prevalence of Cancer and Other Diseases
5.1.2 Growing Focus on Personalized Medicines
5.2 Key Market Restraints
5.2.1 Lack of Skilled Professionals
5.2.2 Stringency of Government Regulations
5.3 Key Market Opportunities
5.3.1 Rise in Number of Clinical Trials for Anticancer Drugs
5.4 Future Trends
5.4.1 Development of New Technologies and Launch of Products
5.5 Impact Analysis
6. Anatomic Pathology Market – Asia Pacific Analysis
6.1 Asia Pacific Anatomic Pathology Market Revenue Forecast and Analysis
7. Anatomic Pathology Market Analysis – By Product and Service
7.1 Overview
7.2 Anatomic Pathology Market, by Product and Service (2020 and 2028)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8. Anatomic Pathology Market Analysis – By Application
8.1 Overview
8.2 Anatomic Pathology Market, by Application (2020 and 2028)
8.3 Disease Diagnosis
8.3.1 Overview
8.3.2 Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Drug Discovery and Development
8.4.1 Overview
8.4.2 Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9. Anatomic Pathology Market Analysis – By End User
9.1 Overview
9.2 Anatomic Pathology Market, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Research Laboratories
9.4.1 Overview
9.4.2 Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
10. Anatomic Pathology Market –Asia Pacific Analysis
10.1 Asia Pacific: Anatomic Pathology Market
10.1.1 Overview
10.1.2 Asia Pacific: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 China: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 China Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.4 China Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.5 China Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 Japan: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1.1 Japan: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.6 Japan Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.7 Japan Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)
10.1.8 Japan Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)
10.1.9 Japan Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.10 Japan Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.10.1 India: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.10.1.1 India: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.11 India Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.12 India Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.13 India Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.13.1 South Korea: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.13.1.1 South Korea: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.14 South Korea Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.15 South Korea Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.16 South Korea Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.16.1 Australia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.16.1.1 Australia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.17 Australia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.18 Australia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.19 Australia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.19.1 Rest of Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.19.1.1 Rest of Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.20 Rest of Asia Pacific Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.21 Rest of Asia Pacific Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.22 Rest of Asia Pacific Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Anatomic Pathology Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Anatomic Pathology Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hologic, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Agilent Technologies, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioGenex
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Diapath S.p.A.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio SB
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERCK KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BD
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 PHC Holdings Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 2. China Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. China Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Japan Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 10. India Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. India Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. South Korea Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 13. South Korea Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 16. Australia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. Australia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Asia Pacific Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
Table 23. Glossary of Terms, Anatomic Pathology Market
LIST OF FIGURES
Figure 1. Anatomic Pathology Market Segmentation
Figure 2. Anatomic Pathology Market Segmentation, By Country
Figure 3. Anatomic Pathology Market Overview
Figure 4. Services Segment Held Largest Share of Anatomic Pathology Market
Figure 5. Asia Pacific Anatomic Pathology Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 7. Asia Pacific Anatomic Pathology Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Anatomic Pathology Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Anatomic Pathology Market Revenue Share, by Product and Service (2020 and 2028)
Figure 10. Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Anatomic Pathology Market Revenue Share, by Application (2020 and 2028)
Figure 14. Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Anatomic Pathology Market Revenue Share, by End User (2020 and 2028)
Figure 18. Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Asia Pacific: Anatomic Pathology Market, by Key Country – Revenue (2021) (USD Million)
Figure 23. Asia Pacific: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
Figure 24. China: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Japan: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. India: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Australia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Rest of Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- F. HOFFMANN-LA ROCHE LTD.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath S.p.A.
- Bio SB
- MERCK KGaA
- BD
- PHC Holdings Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific anatomic pathology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific anatomic pathology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.